SFI
RNAM

Susquehanna Fundamental Investments’s Avidity Biosciences RNAM Stock Holding History

Susquehanna Fundamental Investments’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-58,769
Closed -$1.73M – 961
2025
Q1 		$1.73M Buy
+58,769
New +$1.83M 0.02% 555
2021
Q4 		– Sell
-9,550
Closed -$235K – 1719
2021
Q3 		$235K Buy
+9,550
New +$208K ﹤0.01% 1487
2020
Q4 		– Sell
-17,642
Closed -$497K – 1590
2020
Q3 		$497K Buy
+17,642
New +$510K 0.01% 879

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna Fundamental Investments's RNAM Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Avidity Biosciences (RNAM) in Q2 2025, closing a stake of 58,769 shares — an estimated $1.73M sold.

Susquehanna Fundamental Investments first reported a position in RNAM in Q3 2020 and held it in 3 quarters. The position peaked at $1.73M in Q1 2025. 206 funds tracked by Wall St. Rank hold RNAM as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Avidity Biosciences position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 58,769 Avidity Biosciences shares in Q2 2025, an estimated $1.73M.
  • Susquehanna Fundamental Investments first reported a position in Avidity Biosciences in Q3 2020 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's Avidity Biosciences position peaked at $1.73M in Q1 2025.
  • 206 funds tracked by Wall St. Rank held Avidity Biosciences as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.